Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) last traded at ₹76.3, a market capitalisation of ₹236 crore, on a P/E of 56.5. Over the past 52 weeks the stock has ranged between ₹50.3 and ₹100. Aarey Drugs & Pharmaceuticals Ltd last reported results for the quarter ended Jun 2026, with sales of ₹44.63 crore and net profit of ₹1.02 crore. Figures are as of 25 Aug 2026 and are not real time.
Aarey Drugs & Pharmaceuticals Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Aarey Drugs & Pharmaceuticals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹44.63 cr, down 56.3% from ₹102 cr a year earlier. Net profit was ₹1.02 cr, down 25.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 105 | 134 | 108 | 102 | 84.16 | 96.43 | 189 | 44.63 |
| Expenses | 101 | 132 | 112 | 101 | 81.52 | 97.94 | 185 | 43.31 |
| Operating profit | 3.72 | 2.2 | -4.21 | 1.71 | 2.64 | -1.51 | 4.34 | 1.32 |
| OPM % | 3.54% | 1.64% | -3.89% | 1.67% | 3.14% | -1.57% | 2.29% | 2.96% |
| Other income | 0.02 | 0.68 | 7.54 | 1.55 | 0.79 | 4.18 | -0.43 | 1.72 |
| Interest | 0.49 | 0.58 | 1.3 | 1.04 | 1.26 | 0.92 | 1.78 | 1.67 |
| Depreciation | 1.51 | 0.9 | 0.41 | 0.49 | 0.69 | 0.83 | 0.85 | 0.85 |
| Profit before tax | 1.74 | 1.4 | 1.62 | 1.73 | 1.48 | 0.92 | 1.28 | 0.52 |
| Tax % | 8.62% | 48.57% | 71.60% | 20.81% | 31.08% | 38.04% | -21.88% | -98.08% |
| Net profit | 1.6 | 0.72 | 0.47 | 1.37 | 1.02 | 0.57 | 1.56 | 1.02 |
| EPS (₹) | 0.57 | 0.25 | 0.17 | 0.48 | 0.36 | 0.20 | 0.55 | 0.36 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Aarey Drugs & Pharmaceuticals Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 348 | 493 | 419 | 396 | 474 | 472 | 415 |
| Operating profit | 5 | 11 | 8 | 4 | 3 | 7 | 7 |
| OPM % | 1.3% | 2.3% | 1.8% | 1.1% | 0.6% | 1.5% | 1.6% |
| Net profit | 7 | 7 | 4 | 5 | 4 | 4 | 4 |
| EPS (₹) | 2.78 | 2.58 | 1.49 | 1.67 | 1.42 | 1.40 | 1.47 |
TTM is the trailing twelve months to the most recent quarter.
Aarey Drugs & Pharmaceuticals Ltd growth and returns
- 10 Years
- 7%
- 5 Years
- 6%
- 3 Years
- 4%
- TTM
- -8%
- 10 Years
- 12%
- 5 Years
- -9%
- 3 Years
- 2%
- TTM
- 0%
- 10 Years
- 7%
- 5 Years
- 15%
- 3 Years
- 19%
- 1 Year
- 25%
- 10 Years
- 5%
- 5 Years
- 4%
- 3 Years
- 3%
- Last Year
- 3%
Aarey Drugs & Pharmaceuticals Ltd shareholding pattern
Promoters held 37.71% at Jun 2026, down from 44.80% at Jun 2025. FIIs 4.81% and DIIs 1.62%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 45.44% | 44.80% | 44.80% | 44.80% | 44.80% | 39.05% | 37.71% | 37.71% |
| FIIs | 2.75% | 2.34% | 2.34% | 1.97% | 1.13% | 3.86% | 4.18% | 4.81% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.62% | 1.62% |
| Public | 51.81% | 52.86% | 52.86% | 53.23% | 54.07% | 57.09% | 56.49% | 55.87% |
| No. of shareholders | 16,676 | 16,288 | 16,257 | 15,796 | 14,897 | 14,063 | 14,188 | 13,478 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Aarey Drugs & Pharmaceuticals Ltd corporate filings
- Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatelow impact
Cruxal's analysis: Aarey Drugs & Pharmaceuticals Ltd has fulfilled its regulatory obligation under SEBI…
Read the full analysis - Outcome of Board Meeting held on friday, 14th August, 2026Board Meetinghigh impact
Cruxal's analysis: Aarey Drugs & Pharmaceuticals Limited reported a sharp decline in financial performance…
Read the full analysis - Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve This is to intimate ....Board Meetinglow impact
Cruxal's analysis: Aarey Drugs & Pharmaceuticals Ltd. has formally intimated the stock exchanges regarding a…
Read the full analysis - Allotment of Equity Shares Pursuant to Conversion of WarrantsOthersmedium impact
Cruxal's analysis: Aarey Drugs & Pharmaceuticals Ltd. has approved the allotment of 25.20 lakh equity shares…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Aarey Drugs & Pharmaceuticals Ltd
Cruxal reads every Aarey Drugs & Pharmaceuticals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.